OBJECTIVES: To test the efficacy of a simple intervention method to reduce risk factors for type 2 diabetes (DM) and cardiovascular disease (CVD) in Alaskan Eskimos. STUDY DESIGN: The study consisted of 1) a comprehensive screening for risk factors of 454 individuals in 4 villages, 2) a 4-year intervention and 3) a repetition of the screening in year 5 to test the efficacy of the intervention. METHODS: Personal counseling (1hr/year) stressed the consumption of more traditional foods high in omega-3 fatty acids and less of certain specific store-bought foods high in palmitic acid, which was identified as being associated with glucose intolerance. RESULTS: The intervention resulted in significant reductions in plasma concentrations of total cholesterol (p = 0.0001), LDL cholesterol (p = 0.0001), fasting glucose (p = 0.0001), diastolic blood pressure (p = 0.0007) and improved glucose tolerance (p = 0.0006). This occurred without loss of body weight. Sixty percent of the participants had improved glucose tolerance; only one of the 44 originally identified with impaired glucose tolerance (IGT) developed DM during the study. CONCLUSIONS: Dramatic improvements of risk factors for DM and CVD were achieved in the intervention by primarily stressing the need for changes in the consumption of specific fats. The results suggest that fat consumption is an important risk factor for DM.
OBJECTIVES: To test the efficacy of a simple intervention method to reduce risk factors for type 2 diabetes (DM) and cardiovascular disease (CVD) in Alaskan Eskimos. STUDY DESIGN: The study consisted of 1) a comprehensive screening for risk factors of 454 individuals in 4 villages, 2) a 4-year intervention and 3) a repetition of the screening in year 5 to test the efficacy of the intervention. METHODS: Personal counseling (1hr/year) stressed the consumption of more traditional foods high in omega-3 fatty acids and less of certain specific store-bought foods high in palmitic acid, which was identified as being associated with glucose intolerance. RESULTS: The intervention resulted in significant reductions in plasma concentrations of total cholesterol (p = 0.0001), LDL cholesterol (p = 0.0001), fasting glucose (p = 0.0001), diastolic blood pressure (p = 0.0007) and improved glucose tolerance (p = 0.0006). This occurred without loss of body weight. Sixty percent of the participants had improved glucose tolerance; only one of the 44 originally identified with impaired glucose tolerance (IGT) developed DM during the study. CONCLUSIONS: Dramatic improvements of risk factors for DM and CVD were achieved in the intervention by primarily stressing the need for changes in the consumption of specific fats. The results suggest that fat consumption is an important risk factor for DM.
Authors: Sven O E Ebbesson; Richard B Devereux; Shelley Cole; Lars O E Ebbesson; Richard R Fabsitz; Karin Haack; William S Harris; Wm James Howard; Sandra Laston; Juan Carlos Lopez-Alvarenga; Jean W MacCluer; Peter M Okin; M Elizabeth Tejero; V Saroja Voruganti; Charlotte R Wenger; Barbara V Howard; Anthony G Comuzzie Journal: Am Heart J Date: 2010-06 Impact factor: 4.749
Authors: Kathryn R Koller; Jesse S Metzger; Stacey E Jolly; Jason G Umans; Scarlett E Hopkins; Cristiane Kaufmann; Amy S Wilson; Sven O E Ebbesson; Terry W Raymer; Melissa A Austin; Barbara V Howard; Bert B Boyer Journal: Diabetes Res Clin Pract Date: 2015-03-11 Impact factor: 5.602
Authors: Sven O E Ebbesson; M Elizabeth Tejero; Juan Carlos López-Alvarenga; William S Harris; Lars O E Ebbesson; Richard B Devereux; Jean W MacCluer; Charlotte Wenger; Sandra Laston; Richard R Fabsitz; Barbara V Howard; Anthony G Comuzzie Journal: Int J Circumpolar Health Date: 2010-08-18 Impact factor: 1.228
Authors: J Sonya Haw; Karla I Galaviz; Audrey N Straus; Alysse J Kowalski; Matthew J Magee; Mary Beth Weber; Jingkai Wei; K M Venkat Narayan; Mohammed K Ali Journal: JAMA Intern Med Date: 2017-12-01 Impact factor: 21.873
Authors: Sara K Moses; Alex V Whiting; Gerald R Bratton; Robert J Taylor; Todd M O'Hara Journal: Int J Circumpolar Health Date: 2009-02 Impact factor: 1.228
Authors: Stacey E Jolly; Kathryn R Koller; Jesse S Metzger; Gretchen M Day; Angela Silverman; Scarlett E Hopkins; Melissa A Austin; Bernadette Boden-Albala; Sven O E Ebbesson; Bert B Boyer; Barbara V Howard; Jason G Umans Journal: J Clin Hypertens (Greenwich) Date: 2015-02-03 Impact factor: 3.738